AJNR Am J Neuroradiol

1. XING Z, Yu L, Yu S, Yu F, et al
   T2/FLAIR Mismatch Subregion as an Independent Prognostic Biomarker in IDH-Mutant and 1p/19q Noncodeletion Astrocytoma.
   AJNR Am J Neuroradiol. 2026;47:1604-1612.
   

   >> Share

   
   

   
   Br J Neurosurg

2. HONG S, Takami H, Umekawa M, Shinya Y, et al
   Systemic immune-inflammation and response indices is associated with early but not long-term survival after primary stereotactic radiosurgery for brain metastases.
   Br J Neurosurg. 2026 Jun 10:1-9. doi: 10.1080/02688697.2026.2682819.
   

   >> Share

   
   

   
   Childs Nerv Syst

3. QADRI HM, Irshad S, Chaudhry HF, Asif MA, et al
   Primary Intracranial High Grade Congenital Glial Lesions (PIHGCL): A systematic review of case reports from 1985 to 2025.
   Childs Nerv Syst. 2026;42:246.
   

   >> Share

   
   

   
   Clin Cancer Res

4. GAN HK, Cher L, Inglis PL, Lwin Z, et al
   A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastoma.
   Clin Cancer Res. 2026 Jun 10. doi: 10.1158/1078-0432.CCR-25-3608.
   

   >> Share

   
   

   
   Eur J Cancer

5. OSTROWSKA B, Domanska-Czyz K, Giza A, Taszner M, et al
   The long-term efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in the treatment of primary central nervous system lymphoma: A real-world report from the Polish Lymphoma Research Group.
   Eur J Cancer. 2026;241:116789.
   

   >> Share

   
   

   
   J Natl Cancer Inst

6. DEE EC, Pike LRG, Imber BS
   Brain metastases among older people with cancer.
   J Natl Cancer Inst. 2026 Jun 11:djag141. doi: 10.1093.
   

   >> Share

   
   

   
   J Neurooncol

7. ZHANG L, Feng M, Yang Y, Qi Z, et al
   A comparative study of Ommaya reservoir versus lumbar puncture for intrathecal chemotherapy in patients with leptomeningeal metastasis: a systematic review and meta-analysis.
   J Neurooncol. 2026;178:38.
   

   >> Share

   
   
8. TROY C, Laird DG, Brimley C, Pinto S, et al
   Neoadjuvant chemotherapy for pineal region tumors.
   J Neurooncol. 2026;178:37.
   

   >> Share

   
   
9. HIGASHINO M, Tanaka K, Ishihara T, Nagashima H, et al
   Long-term clinical outcomes and recurrence factors in intracranial germinoma.
   J Neurooncol. 2026;178:43.
   

   >> Share

   
   
10. BENITEZ-ROCHA RD, Cabrera-Galeana P, Reyes JA, Villasenor-Navarro Y, et al
    Prognostic impact of concomitant leptomeningeal disease in breast cancer patients with brain metastases: a large single-center cohort study.
    J Neurooncol. 2026;178:49.
    

    >> Share

    
    
11. FARAJ CA, McCutcheon IE
    Loss of pituitary hormone function after stereotactic radiosurgery for pituitary adenomas: mechanisms and management.
    J Neurooncol. 2026;178:48.
    

    >> Share

    
    
12. BEA SINTES M, Velilla-Alonso G, Herrero-San Martin A, Gallego Perez-Larraya J, et al
    Risk factors and long-term outcomes in smart syndrome: a multicenter study.
    J Neurooncol. 2026;178:53.
    

    >> Share

    
    
13. JIANG LQ, Wan CY, Kang J, Fu R, et al
    Survival outcomes and molecular predictors in small cell lung cancer with brain metastases receiving immunotherapy.
    J Neurooncol. 2026;178:51.
    

    >> Share

    
    
14. ZHANG Y, Wang H, Wang J, Sui Y, et al
    Targeting VAMP5 suppresses PLK1-driven growth of gliomas with high NDRG4 expression.
    J Neurooncol. 2026;178:50.
    

    >> Share

    
    
15. LANMAN TA, Gonzalez Castro LN, Perlow HK, Youssef G, et al
    Contemporary practice patterns in IDH-mutant glioma management: a multidisciplinary multi-institutional survey.
    J Neurooncol. 2026;178:54.
    

    >> Share

    
    
16. PARKER M, Carmichael A, Lucas CG Jr, Schreck KC, et al
    Survival after hypofractionated radiation versus standard radiation in glioblastoma by MGMT promoter methylation status and age: an analysis of the national cancer database.
    J Neurooncol. 2026;178:55.
    

    >> Share

    
    
17. MIZUTANI Y, Hori YS, Kattaa AH, Harary PM, et al
    Laser interstitial thermal therapy (LITT) for brain metastases: a systematic review and pooled analysis of Efficacy/Safety and the role of combination treatments.
    J Neurooncol. 2026;178:56.
    

    >> Share

    
    
18. SEIFERT AM, Richter S, Sagerer A, Lemnian I, et al
    Comparison between molecular and histological IDH-wild-type glioblastoma and extensive subgroup analysis of IDH-wild-type astrocytic tumors without genomic glioblastoma-defining alterations.
    J Neurooncol. 2026;178:58.
    

    >> Share

    
    
19. LIU L, Huang S, Huang Y, Xu J, et al
    Development and validation of a machine learning-based model for predicting delirium risk in postoperative brain tumor patients in the Intensive Care Unit.
    J Neurooncol. 2026;178:57.
    

    >> Share

    
    
20. BASARAN AE, Braune M, Barrantes-Freer A, Muller WC, et al
    FOXC1 as a molecular predictor of postoperative peritumoral edema resolution in meningiomas.
    J Neurooncol. 2026;178:59.
    

    >> Share

    
    

    
    J Neurosurg

21. NAGARAJA TN, Bartlett S, Cabral G, Acharya PC, et al
    Imaging, histological, and molecular characterization of a preclinical, orthotopic model of recurrent glioblastoma following image-guided laser ablation of the primary tumor.
    J Neurosurg. 2026 Jun 5:1-14. doi: 10.3171/2026.1.JNS241395.
    

    >> Share

    
    

    
    J Nucl Med

22. BROWN MK, Cai Z, Ganga-Sah Y, Alshafai L, et al
    Treatment of Human Glioblastoma Multiforme in NRG Mice by Convection-Enhanced Delivery of EGFR-Targeted or Nontargeted Auger Electron-Emitting (197g)Hg-Labeled Gold Nanoparticles.
    J Nucl Med. 2026 Jun 11:jnumed.125.271785. doi: 10.2967/jnumed.125.271785.
    

    >> Share

    
    

    
    JAMA

23. AIZER AA, Shin KY, Tanguturi S
    Treatment of Brain Metastases with Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation-Reply.
    JAMA. 2026 Jun 11. doi: 10.1001/jama.2026.6341.
    

    >> Share

    
    
24. LI S, Jiang R
    Treatment of Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation.
    JAMA. 2026 Jun 11. doi: 10.1001/jama.2026.6338.
    

    >> Share

    
    
25. HAN XY
    Treatment of Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation.
    JAMA. 2026 Jun 11. doi: 10.1001/jama.2026.6332.
    

    >> Share

    
    
26. SAMALA SK, Raut S
    Treatment of Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation.
    JAMA. 2026 Jun 11. doi: 10.1001/jama.2026.6335.
    

    >> Share

    
    

    
    Neuro Oncol

27. SCHRECK KC, de la Fuente MI, Fat MJL, Maas SLN, et al
    BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directions.
    Neuro Oncol. 2026 Jun 8:noag135. doi: 10.1093.
    

    >> Share

    
    
28. HUQ S, Gatesman TA, Abou-Al-Shaar H, Raleigh DR, et al
    Genomic hallmarks of depot medroxyprogesterone acetate-associated meningiomas.
    Neuro Oncol. 2026 Jun 8:noag136. doi: 10.1093.
    

    >> Share

    
    
29. DRUCKER KL, Panda A, Decker PA, Kosel ML, et al
    DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma.
    Neuro Oncol. 2026;28:1397-1409.
    

    >> Share

    
    
30. ALI JS, Bass JK, Wang F, Yuan X, et al
    The impact of hearing loss on cognitive outcomes among children treated with radiation therapy for ependymoma.
    Neuro Oncol. 2026;28:1517-1526.
    

    >> Share

    
    

    
    Neuroradiology

31. SORKUN M, Samanci MY, Peker S, Aygun MS, et al
    Early response evaluation of radiosurgery in intracranial meningiomas: insights from dynamic contrast?enhanced MRI.
    Neuroradiology. 2026 Jun 10. doi: 10.1007/s00234-026-04067.
    

    >> Share

    
    
32. ABDALLAH A, Altuwayjiri B, Albloshi AMK, Althbiti A, et al
    Integrated CT-PET radiogenomics and graph-based multi-task learning for preoperative prediction of key glioma molecular markers.
    Neuroradiology. 2026 Jun 6. doi: 10.1007/s00234-026-04053.
    

    >> Share

    
    

    
    Neurosurg Clin N Am

33. WARD M, Brown EDL, Maity A, Larry Lo SF, et al
    Intramedullary Spinal Cord Tumors in the Elderly Patient.
    Neurosurg Clin N Am. 2026;37:363-376.
    

    >> Share

    
    
34. HALAC E, Begagic E, Pojskic M, Arnautovic K, et al
    Treatment Strategies and Outcomes for Spinal Low-grade Gliomas: A Systematic Review of the Past Quarter Century.
    Neurosurg Clin N Am. 2026;37:331-351.
    

    >> Share

    
    
35. LU VM, Jallo GI, Shimony N
    The History of Intramedullary Spinal Cord Tumor Surgery.
    Neurosurg Clin N Am. 2026;37:271-280.
    

    >> Share

    
    

    
    PLoS One

36. GONG Y, Guo H, Ding H, Hu X, et al
    Characterizing malignant prognostic signatures in primary glioma based on single-cell and bulk transcriptome sequencing.
    PLoS One. 2026;21:e0349749.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

37. LOZZI B, Gatesman TA, Dasgupta P, Sardar D, et al
    Hp1bp3 loss links chromatin reorganization to metabolic vulnerability in glioma.
    Proc Natl Acad Sci U S A. 2026;123:e2601061123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share